Hyungseok Kim, Director of Biomedical Science at Hwasun Chonnam National University Hospital, Receives Commendation from Korea Health Industry Development Institute President

Hyungseok Kim, Director of the Institute of Biomedical Science at Hwasun Chonnam National University Hospital.

Hwasun Chonnam National University Hospital announced on the 4th that Hyungseok Kim, Director of the Institute of Biomedical Science, received a commendation from the President of the Korea Health Industry Development Institute in recognition of his contributions to the advancement of the domestic healthcare industry.

This commendation is a government award presented by the Ministry of Health and Welfare and the Korea Health Industry Development Institute. It is given to individuals and organizations that have received support for the commercialization of healthcare technologies and have achieved significant results contributing to the development of the domestic industry.

Director Kim was especially recognized for his achievements in establishing a practical support system that enables local companies to verify technologies and connect them to clinical trials and commercialization, based on the 'K-Biohealth Regional Center Support Project,' a healthcare technology commercialization support initiative.

Since assuming the position of Director of the Institute of Biomedical Science in 2022, Director Kim has opened the hospital’s research and clinical infrastructure to companies and established a full-cycle technology commercialization model that allows bio startups to carry out the entire process of research, clinical trials, and commercialization in collaboration with the hospital. Through these efforts, he has enhanced the growth potential of local bio companies and strengthened the hospital-centered industry-academia-research-hospital cooperation system.

Operating dedicated spaces for bio companies within the hospital’s Center for Future Medical Innovation and building an open innovation environment are also key achievements. Director Kim created an open innovation ecosystem where companies and clinicians can collaborate on research and discuss commercialization strategies, while providing resident companies with tailored consulting and optimal research and office environments to support their early settlement and growth.

He also led the establishment of a digital-based clinical support platform, thereby strengthening the hospital-centered precision medicine infrastructure. By setting up integrated clinical information management and a customized technical support system for companies, he has greatly improved technological accessibility and research efficiency in the regional biohealth industry.

Director Hyungseok Kim stated, "I feel a great sense of fulfillment that our efforts to build a hospital-centered biohealth innovation ecosystem have been recognized at the national level through this award," and added, "I will continue to expand the technology commercialization foundation where research, clinical practice, and companies can grow together, thereby contributing to the development of the regional industry."

This content was produced with the assistance of AI translation services.